Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office
Fish and Richardson
Boehringer Ingelheim
Harvard Business School
Farmers Insurance

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020822

« Back to Dashboard
NDA 020822 describes CELEXA, which is a drug marketed by Forest Labs and is included in two NDAs. It is available from three suppliers. Additional details are available on the CELEXA profile page.

The generic ingredient in CELEXA is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.

Summary for 020822

Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details

Pharmacology for NDA: 020822

Mechanism of ActionSerotonin Uptake Inhibitors

Medical Subject Heading (MeSH) Categories for 020822

Suppliers and Packaging for NDA: 020822

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
citalopram hydrobromide
TABLET;ORAL 020822 NDA Allergan USA, Inc. 0456-4010 0456-4010-01 100 TABLET, FILM COATED in 1 BOTTLE (0456-4010-01)
citalopram hydrobromide
TABLET;ORAL 020822 NDA Allergan USA, Inc. 0456-4020 0456-4020-01 100 TABLET, FILM COATED in 1 BOTTLE (0456-4020-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Apr 27, 2000TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Jul 17, 1998TE:ABRLD:Yes

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 40MG BASE
Approval Date:Jul 17, 1998TE:ABRLD:Yes

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Farmers Insurance
Cantor Fitzgerald
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus